Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 9 | 2024 | 106 | 3.770 |
Why?
|
| Tuberculosis | 8 | 2024 | 76 | 2.580 |
Why?
|
| Bacterial Proteins | 4 | 2024 | 580 | 1.150 |
Why?
|
| Macrophages | 5 | 2024 | 515 | 0.920 |
Why?
|
| Mycobacterium bovis | 3 | 2022 | 14 | 0.890 |
Why?
|
| Fusobacterium nucleatum | 1 | 2024 | 9 | 0.890 |
Why?
|
| Mycobacterium Infections | 1 | 2022 | 16 | 0.770 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 223 | 0.750 |
Why?
|
| Antigens, Bacterial | 2 | 2020 | 144 | 0.720 |
Why?
|
| Arginine | 1 | 2018 | 75 | 0.570 |
Why?
|
| Oxidative Stress | 2 | 2024 | 990 | 0.520 |
Why?
|
| Phagosomes | 3 | 2019 | 33 | 0.480 |
Why?
|
| BCG Vaccine | 4 | 2022 | 12 | 0.400 |
Why?
|
| GTP-Binding Proteins | 2 | 2011 | 58 | 0.390 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2009 | 3 | 0.320 |
Why?
|
| Mice | 7 | 2024 | 6490 | 0.260 |
Why?
|
| Animals | 9 | 2024 | 16695 | 0.250 |
Why?
|
| Microbial Viability | 1 | 2024 | 42 | 0.220 |
Why?
|
| Oxidoreductases | 1 | 2024 | 79 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 1804 | 0.190 |
Why?
|
| Crystallography, X-Ray | 1 | 2022 | 285 | 0.180 |
Why?
|
| Vaccination | 2 | 2022 | 332 | 0.180 |
Why?
|
| Drug Discovery | 1 | 2022 | 106 | 0.180 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1554 | 0.180 |
Why?
|
| Host-Pathogen Interactions | 2 | 2022 | 203 | 0.180 |
Why?
|
| Lung | 1 | 2024 | 484 | 0.180 |
Why?
|
| Drug Design | 1 | 2022 | 183 | 0.170 |
Why?
|
| Virulence | 2 | 2019 | 238 | 0.170 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 15 | 0.170 |
Why?
|
| Guinea Pigs | 1 | 2020 | 144 | 0.170 |
Why?
|
| Humans | 7 | 2024 | 42163 | 0.160 |
Why?
|
| Interferon-gamma | 2 | 2011 | 268 | 0.150 |
Why?
|
| Necrosis | 1 | 2019 | 54 | 0.150 |
Why?
|
| Chemokines | 1 | 2019 | 97 | 0.140 |
Why?
|
| Sulfhydryl Compounds | 1 | 2018 | 49 | 0.140 |
Why?
|
| Antitubercular Agents | 1 | 2018 | 33 | 0.140 |
Why?
|
| Vaccines | 1 | 2019 | 64 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 71 | 0.140 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 88 | 0.140 |
Why?
|
| Mycobacterium smegmatis | 2 | 2015 | 9 | 0.130 |
Why?
|
| Flow Cytometry | 1 | 2018 | 411 | 0.130 |
Why?
|
| DNA Damage | 1 | 2018 | 358 | 0.120 |
Why?
|
| Lymph | 1 | 2015 | 1 | 0.120 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 5 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 518 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2015 | 73 | 0.110 |
Why?
|
| Antioxidants | 1 | 2018 | 439 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 683 | 0.110 |
Why?
|
| 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 1 | 2014 | 1 | 0.110 |
Why?
|
| Mycolic Acids | 1 | 2014 | 2 | 0.110 |
Why?
|
| Tuberculosis Vaccines | 1 | 2013 | 3 | 0.110 |
Why?
|
| Proteome | 1 | 2015 | 150 | 0.110 |
Why?
|
| Vaccines, Synthetic | 1 | 2013 | 78 | 0.100 |
Why?
|
| Lysosomes | 2 | 2011 | 88 | 0.100 |
Why?
|
| Immunity, Innate | 2 | 2011 | 168 | 0.090 |
Why?
|
| Aging | 1 | 2015 | 764 | 0.080 |
Why?
|
| SNARE Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 37 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 185 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 295 | 0.070 |
Why?
|
| Protein Binding | 1 | 2009 | 1076 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1617 | 0.060 |
Why?
|
| Female | 1 | 2024 | 24018 | 0.050 |
Why?
|
| Granuloma | 1 | 2022 | 24 | 0.050 |
Why?
|
| Cell Death | 1 | 2022 | 277 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2009 | 2111 | 0.040 |
Why?
|
| Mesentery | 1 | 2015 | 9 | 0.030 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2015 | 20 | 0.030 |
Why?
|
| Connexins | 1 | 2015 | 28 | 0.030 |
Why?
|
| Glycosylation | 1 | 2015 | 111 | 0.030 |
Why?
|
| Gap Junctions | 1 | 2015 | 49 | 0.030 |
Why?
|
| Glycocalyx | 1 | 2015 | 37 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 78 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 256 | 0.030 |
Why?
|
| Microbiological Techniques | 1 | 2014 | 13 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 92 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2015 | 91 | 0.030 |
Why?
|
| Cell Wall | 1 | 2014 | 55 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 158 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 118 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2014 | 106 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 193 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 140 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2013 | 181 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1188 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1559 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2015 | 324 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 379 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2011 | 6 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 973 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2011 | 83 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2014 | 875 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 246 | 0.020 |
Why?
|
| Autophagy | 1 | 2011 | 136 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 448 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 357 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3701 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 1416 | 0.020 |
Why?
|
| Male | 1 | 2015 | 22779 | 0.010 |
Why?
|